Search Results

Bortezomib 100mg 100mg  | Purity Not Available

Adooq Bioscience

Bortezomib is a highly selective, reversible inhibitor of the 26S proteasome

More Information Supplier Page

×

Bortezomib 100mg

Bortezomib 10mg 10mg  | Purity Not Available

Adooq Bioscience

Bortezomib is a highly selective, reversible inhibitor of the 26S proteasome

More Information Supplier Page

×

Bortezomib 10mg

Bosutinib 50mg 50mg  | Purity Not Available

Adooq Bioscience

Bosutinib (SKI-606) is a tyrosine kinase inhibitor undergoing research for use in the treatment of cancer.

More Information Supplier Page

×

Bosutinib 50mg

Brivanib alaninate 10mg 10mg  | Purity Not Available

Adooq Bioscience

Brivanib alaninate (BMS-582664) is a dual tyrosine kinase inhibitor of VEGFR and FGFR signaling.

More Information Supplier Page

×

Brivanib alaninate 10mg

BSI-201 10mg 10mg  | Purity Not Available

Adooq Bioscience

BSI-201 is a potent inhibitor of PARP-1 and has been shown to cross the blood-brain barrier.

More Information Supplier Page

×

BSI-201 10mg

BS-181 HCl 50mg 50mg  | Purity Not Available

Adooq Bioscience

BS-181 HCl is a potential anti-tumor agent as CDK7 inhibitor.

More Information Supplier Page

×

BS-181 HCl 50mg

BS-181 HCl 25mg 25mg  | Purity Not Available

Adooq Bioscience

BS-181 HCl is a potential anti-tumor agent as CDK7 inhibitor.

More Information Supplier Page

×

BS-181 HCl 25mg

BS-181 HCl 100mg 100mg  | Purity Not Available

Adooq Bioscience

BS-181 HCl is a potential anti-tumor agent as CDK7 inhibitor.

More Information Supplier Page

×

BS-181 HCl 100mg

BS-181 HCl 10mg 10mg  | Purity Not Available

Adooq Bioscience

BS-181 HCl is a potential anti-tumor agent as CDK7 inhibitor.

More Information Supplier Page

×

BS-181 HCl 10mg

Brivanib alaninate 50mg 50mg  | Purity Not Available

Adooq Bioscience

Brivanib alaninate (BMS-582664) is a dual tyrosine kinase inhibitor of VEGFR and FGFR signaling.

More Information Supplier Page

×

Brivanib alaninate 50mg